https://www.selleckchem.com/pr....oducts/zebularine.ht
Of these 37 patients, 8 (21.6%) had a complication by last follow-up (death 2; residual aneurysm 2; parent artery occlusion 4). This resulted in an incidence rate of 0.018 complications per patient at-risk month (95% CI 0.008-0.035). These data suggest that the use of flow-diverting stents for treatment of aneurysms in children may be safe and that FDA approval for this use should be evaluated. Although this analysis is comprised of case reports and case series, it represents the best attempt thus far to quantify the risk of using fl
Like
Comment
Share
